Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Muscle derangement and alteration of the nutritional machinery in NSCLC.

Trestini I, Gkountakos A, Carbognin L, Avancini A, Lanza M, Molfino A, Friso S, Corbo V, Tortora G, Scarpa A, Milella M, Bria E, Pilotto S.

Crit Rev Oncol Hematol. 2019 Sep;141:43-53. doi: 10.1016/j.critrevonc.2019.06.007. Epub 2019 Jun 15. Review.

PMID:
31228648
2.

Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.

Grandi G, Perrone AM, Chiossi G, Friso S, Toss A, Sammarini M, Facchinetti F, Botticelli L, Palma F, De Iaco P.

Gynecol Oncol. 2019 Jul;154(1):163-168. doi: 10.1016/j.ygyno.2019.04.684. Epub 2019 May 16.

PMID:
31104904
3.

Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII.

Olivieri O, Turcato G, Moruzzi S, Castagna A, Girelli D, Pizzolo F, Friso S, Sandri M, Bassi A, Martinelli N.

J Am Heart Assoc. 2019 Jan 22;8(2):e010973. doi: 10.1161/JAHA.118.010973.

4.

DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis.

Udali S, De Santis D, Ruzzenente A, Moruzzi S, Mazzi F, Beschin G, Tammen SA, Campagnaro T, Pattini P, Olivieri O, Guglielmi A, Choi SW, Friso S.

Front Genet. 2018 Jan 9;8:229. doi: 10.3389/fgene.2017.00229. eCollection 2017.

5.

Hepcidin and DNA promoter methylation in hepatocellular carcinoma.

Udali S, Castagna A, Corbella M, Ruzzenente A, Moruzzi S, Mazzi F, Campagnaro T, De Santis D, Franceschi A, Pattini P, Gottardo R, Olivieri O, Perbellini L, Guglielmi A, Choi SW, Girelli D, Friso S.

Eur J Clin Invest. 2018 Feb;48(2):e12870. doi: 10.1111/eci.12870. Epub 2017 Dec 28.

PMID:
29235098
6.

One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.

Moruzzi S, Guarini P, Udali S, Ruzzenente A, Guglielmi A, Conci S, Pattini P, Martinelli N, Olivieri O, Tammen SA, Choi SW, Friso S.

PLoS One. 2017 Oct 2;12(10):e0185792. doi: 10.1371/journal.pone.0185792. eCollection 2017.

7.

Iron Supplementation Reverses the Reduction of Hydroxymethylcytosine in Hepatic DNA Associated With Chronic Alcohol Consumption in Rats.

Tammen SA, Park JE, Shin PK, Friso S, Chung J, Choi SW.

J Cancer Prev. 2016 Dec;21(4):264-270. doi: 10.15430/JCP.2016.21.4.264. Epub 2016 Dec 30.

8.

The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers.

Moruzzi S, Udali S, Ruzzenente A, Guglielmi A, Guarini P, Martinelli N, Conci S, Mazzi F, Pattini P, Tammen SA, Olivieri O, Pizzolo F, Choi SW, Friso S.

PLoS One. 2016 Dec 9;11(12):e0167534. doi: 10.1371/journal.pone.0167534. eCollection 2016.

9.

Epigenetics in non-alcoholic fatty liver disease.

Lee J, Kim Y, Friso S, Choi SW.

Mol Aspects Med. 2017 Apr;54:78-88. doi: 10.1016/j.mam.2016.11.008. Epub 2016 Nov 23. Review.

PMID:
27889327
10.

One-carbon metabolism and epigenetics.

Friso S, Udali S, De Santis D, Choi SW.

Mol Aspects Med. 2017 Apr;54:28-36. doi: 10.1016/j.mam.2016.11.007. Epub 2016 Nov 19. Review.

PMID:
27876555
11.

Hepatic DNA hydroxymethylation is site-specifically altered by chronic alcohol consumption and aging.

Tammen SA, Park LK, Dolnikowski GG, Ausman LM, Friso S, Choi SW.

Eur J Nutr. 2017 Mar;56(2):535-544. doi: 10.1007/s00394-015-1098-4. Epub 2015 Nov 14.

PMID:
26578530
12.

Reply.

Udali S, Moruzzi S, Ruzzenente A, Choi SW, Friso S.

Hepatology. 2016 May;63(5):1746-7. doi: 10.1002/hep.28271. Epub 2015 Nov 26. No abstract available.

PMID:
26439221
13.

A lifelong exposure to a Western-style diet, but not aging, alters global DNA methylation in mouse colon.

Choi SW, Tammen SA, Liu Z, Friso S.

Nutr Res Pract. 2015 Aug;9(4):358-63. doi: 10.4162/nrp.2015.9.4.358. Epub 2015 May 22.

14.

Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation.

Pizzolo F, Friso S, Morandini F, Antoniazzi F, Zaltron C, Udali S, Gandini A, Cavarzere P, Salvagno G, Giorgetti A, Speziali G, Choi SW, Olivieri O.

J Clin Endocrinol Metab. 2015 Sep;100(9):E1234-41. doi: 10.1210/jc.2015-1760. Epub 2015 Jun 30.

PMID:
26126204
15.

DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma.

Udali S, Guarini P, Ruzzenente A, Ferrarini A, Guglielmi A, Lotto V, Tononi P, Pattini P, Moruzzi S, Campagnaro T, Conci S, Olivieri O, Corrocher R, Delledonne M, Choi SW, Friso S.

Clin Epigenetics. 2015 Apr 14;7:43. doi: 10.1186/s13148-015-0077-1. eCollection 2015.

16.

Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate.

Udali S, Guarini P, Moruzzi S, Ruzzenente A, Tammen SA, Guglielmi A, Conci S, Pattini P, Olivieri O, Corrocher R, Choi SW, Friso S.

Hepatology. 2015 Aug;62(2):496-504. doi: 10.1002/hep.27823. Epub 2015 Apr 28.

PMID:
25833413
17.

Aging alters hepatic DNA hydroxymethylation, as measured by liquid chromatography/mass spectrometry.

Tammen SA, Dolnikowski GG, Ausman LM, Liu Z, Kim KC, Friso S, Choi SW.

J Cancer Prev. 2014 Dec;19(4):301-8. doi: 10.15430/JCP.2014.19.4.301.

18.

An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis.

Marchetti G, Girelli D, Zerbinati C, Lunghi B, Friso S, Meneghetti S, Coen M, Gagliano T, Guastella G, Bochaton-Piallat ML, Pizzolo F, Mascoli F, Malerba G, Bovolenta M, Ferracin M, Olivieri O, Bernardi F, Martinelli N.

Thromb Haemost. 2015 Mar;113(3):655-63. doi: 10.1160/TH14-05-0466. Epub 2014 Nov 6.

PMID:
25374339
19.

Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition.

Lee JH, Friso S, Choi SW.

Nutrients. 2014 Aug 21;6(8):3303-25. doi: 10.3390/nu6083303. Review.

20.

Aging and alcohol interact to alter hepatic DNA hydroxymethylation.

Tammen SA, Dolnikowski GG, Ausman LM, Liu Z, Sauer J, Friso S, Choi SW.

Alcohol Clin Exp Res. 2014 Aug;38(8):2178-85. doi: 10.1111/acer.12477. Epub 2014 Jul 28.

21.

Epigenetics and arterial hypertension: the challenge of emerging evidence.

Friso S, Carvajal CA, Fardella CE, Olivieri O.

Transl Res. 2015 Jan;165(1):154-65. doi: 10.1016/j.trsl.2014.06.007. Epub 2014 Jun 25. Review.

PMID:
25035152
22.

Present and future of anti-ageing epigenetic diets.

Bacalini MG, Friso S, Olivieri F, Pirazzini C, Giuliani C, Capri M, Santoro A, Franceschi C, Garagnani P.

Mech Ageing Dev. 2014 Mar-Apr;136-137:101-15. doi: 10.1016/j.mad.2013.12.006. Epub 2014 Jan 2. Review.

PMID:
24388875
23.

Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.

Olivieri O, Martinelli N, Baroni M, Branchini A, Girelli D, Friso S, Pizzolo F, Bernardi F.

J Am Heart Assoc. 2013 Nov 15;2(6):e000440. doi: 10.1161/JAHA.113.000440.

24.

Nutritional epigenomics: a portal to disease prevention.

Choi SW, Claycombe KJ, Martinez JA, Friso S, Schalinske KL.

Adv Nutr. 2013 Sep 1;4(5):530-2. doi: 10.3945/an.113.004168.

25.

Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk.

Friso S, Udali S, Guarini P, Pellegrini C, Pattini P, Moruzzi S, Girelli D, Pizzolo F, Martinelli N, Corrocher R, Olivieri O, Choi SW.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):348-55. doi: 10.1158/1055-9965.EPI-12-0859. Epub 2013 Jan 8.

26.

Cardiovascular epigenetics: from DNA methylation to microRNAs.

Udali S, Guarini P, Moruzzi S, Choi SW, Friso S.

Mol Aspects Med. 2013 Jul-Aug;34(4):883-901. doi: 10.1016/j.mam.2012.08.001. Epub 2012 Sep 6. Review.

PMID:
22981780
27.

Epigenetics: the link between nature and nurture.

Tammen SA, Friso S, Choi SW.

Mol Aspects Med. 2013 Jul-Aug;34(4):753-64. doi: 10.1016/j.mam.2012.07.018. Epub 2012 Aug 10. Review.

28.

An unexpected explanation for exhaustion.

GranĂ  G, Trecco G, Friso S.

Gastroenterology. 2012 May;142(5):e5-6. doi: 10.1053/j.gastro.2011.11.049. Epub 2012 Mar 23. No abstract available.

PMID:
22449577
29.

Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease.

Friso S, Lotto V, Choi SW, Girelli D, Pinotti M, Guarini P, Udali S, Pattini P, Pizzolo F, Martinelli N, Corrocher R, Bernardi F, Olivieri O.

J Med Genet. 2012 Mar;49(3):192-9. doi: 10.1136/jmedgenet-2011-100195. Epub 2012 Feb 7.

PMID:
22315437
30.

Vitamin B6 and cardiovascular disease.

Friso S, Lotto V, Corrocher R, Choi SW.

Subcell Biochem. 2012;56:265-90. doi: 10.1007/978-94-007-2199-9_14. Review.

PMID:
22116704
31.

Vitamins B6 and cancer.

Choi SW, Friso S.

Subcell Biochem. 2012;56:247-64. doi: 10.1007/978-94-007-2199-9_13. Review.

PMID:
22116703
32.

Nutritional influences on epigenetics and age-related disease.

Park LK, Friso S, Choi SW.

Proc Nutr Soc. 2012 Feb;71(1):75-83. doi: 10.1017/S0029665111003302. Epub 2011 Nov 4. Review.

PMID:
22051144
33.

Epigenetics: A New Bridge between Nutrition and Health.

Choi SW, Friso S.

Adv Nutr. 2010 Nov;1(1):8-16. doi: 10.3945/an.110.1004. Epub 2010 Nov 16.

34.

Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.

Martinelli N, Micaglio R, Consoli L, Guarini P, Grison E, Pizzolo F, Friso S, Trabetti E, Pignatti PF, Corrocher R, Olivieri O, Girelli D.

Exp Diabetes Res. 2012;2012:231502. doi: 10.1155/2012/231502. Epub 2011 Sep 22.

35.

Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia.

Pizzolo F, Blom HJ, Choi SW, Girelli D, Guarini P, Martinelli N, Stanzial AM, Corrocher R, Olivieri O, Friso S.

J Am Coll Nutr. 2011 Feb;30(1):11-8.

PMID:
21697534
36.

Vitamin B6: a challenging link between nutrition and inflammation in CVD.

Lotto V, Choi SW, Friso S.

Br J Nutr. 2011 Jul;106(2):183-95. doi: 10.1017/S0007114511000407. Review.

PMID:
21486513
37.

Folate supplementation differently affects uracil content in DNA in the mouse colon and liver.

Kim KC, Jang H, Sauer J, Zimmerly EM, Liu Z, Chanson A, Smith DE, Friso S, Choi SW.

Br J Nutr. 2011 Mar;105(5):688-93. doi: 10.1017/S0007114510004332. Epub 2011 Jan 21.

38.

Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and vitamin B12.

Tong SY, Kim MK, Lee JK, Lee JM, Choi SW, Friso S, Song ES, Lee KB, Lee JP.

Cancer Causes Control. 2011 Jan;22(1):63-72. doi: 10.1007/s10552-010-9675-6. Epub 2010 Nov 5.

PMID:
21052817
39.

Ageing, chronic alcohol consumption and folate are determinants of genomic DNA methylation, p16 promoter methylation and the expression of p16 in the mouse colon.

Sauer J, Jang H, Zimmerly EM, Kim KC, Liu Z, Chanson A, Smith DE, Mason JB, Friso S, Choi SW.

Br J Nutr. 2010 Jul;104(1):24-30. doi: 10.1017/S0007114510000322. Epub 2010 Mar 8.

40.

Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.

Olivieri O, Martinelli N, Girelli D, Pizzolo F, Friso S, Beltrame F, Lotto V, Annarumma L, Corrocher R.

J Thromb Haemost. 2010 Mar;8(3):463-71. doi: 10.1111/j.1538-7836.2009.03720.x. Epub 2009 Dec 11.

41.

DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic development and aging.

Kim KC, Friso S, Choi SW.

J Nutr Biochem. 2009 Dec;20(12):917-26. doi: 10.1016/j.jnutbio.2009.06.008. Epub 2009 Sep 4. Review.

42.

DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing?

Gemmati D, De Mattei M, Catozzi L, Della Porta M, Serino ML, Ambrosio C, Cuneo A, Friso S, Krampera M, Orioli E, Zeri G, Ongaro A.

Am J Hematol. 2009 Aug;84(8):526-9. doi: 10.1002/ajh.21451. No abstract available.

43.

Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study.

Martinelli N, Olivieri O, Shen GQ, Trabetti E, Pizzolo F, Busti F, Friso S, Bassi A, Li L, Hu Y, Pignatti PF, Corrocher R, Wang QK, Girelli D.

BMC Med Genet. 2009 May 13;10:41. doi: 10.1186/1471-2350-10-41.

44.

Novel serum paraoxonase activity assays are associated with coronary artery disease.

Martinelli N, Girelli D, Olivieri O, Guarini P, Bassi A, Trabetti E, Friso S, Pizzolo F, Bozzini C, Tenuti I, Annarumma L, Schiavon R, Franco Pignatti P, Corrocher R.

Clin Chem Lab Med. 2009;47(4):432-40. doi: 10.1515/CCLM.2009.108.

PMID:
19275503
45.

Two siblings with a homozygous MTHFR C677T (G80A-RFC1) mutation and stroke.

Barbagallo M, Pavone P, Incorpora G, Domenico Praticò A, Romantshik O, Friso S, Spalice A, Nicita F, Polizzi A, Ruggieri M, Iannetti P.

Childs Nerv Syst. 2009 Mar;25(3):361-5. doi: 10.1007/s00381-008-0724-3. Epub 2008 Oct 29.

PMID:
18958479
46.

FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease.

Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E, Sandri M, Friso S, Pizzolo F, Schaeffer L, Heinrich J, Pignatti PF, Corrocher R, Olivieri O.

Am J Clin Nutr. 2008 Oct;88(4):941-9.

PMID:
18842780
47.

Urinary cortisol to cortisone metabolites ratio in prednisone-treated and spontaneously hypertensive patients.

Olivieri O, Pizzolo F, Ravagnani V, Moretti L, Carletto A, Faccini G, Pasini F, Friso S, Corrocher R.

J Hypertens. 2008 Mar;26(3):486-93. doi: 10.1097/HJH.0b013e3282f2d35e.

PMID:
18300859
48.

Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis.

Martinelli N, Trabetti E, Pinotti M, Olivieri O, Sandri M, Friso S, Pizzolo F, Bozzini C, Caruso PP, Cavallari U, Cheng S, Pignatti PF, Bernardi F, Corrocher R, Girelli D.

PLoS One. 2008 Feb 6;3(2):e1523. doi: 10.1371/journal.pone.0001523.

49.

ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome.

Olivieri O, Martinelli N, Bassi A, Trabetti E, Girelli D, Pizzolo F, Friso S, Pignatti PF, Corrocher R.

Clin Exp Med. 2007 Dec;7(4):164-72. doi: 10.1007/s10238-007-0142-y. Epub 2008 Jan 11.

PMID:
18188530
50.

Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension.

Friso S, Pizzolo F, Choi SW, Guarini P, Castagna A, Ravagnani V, Carletto A, Pattini P, Corrocher R, Olivieri O.

Atherosclerosis. 2008 Aug;199(2):323-7. doi: 10.1016/j.atherosclerosis.2007.11.029. Epub 2008 Feb 7.

PMID:
18178212

Supplemental Content

Support Center